In vitro study demonstrates high cytotoxic activity of novel copper(II) complexes in HepG2 liver cancer cells, highlighting their potential as anticancer agents.
A new bis-benzoxazolylhydrazone of 2,6-diacetylpyridine and mononuclear Cu( ii ) complexes based on it have been synthesized. An in vitro study showed that all Cu( ii ) complexes exhibit high cytotoxic activity against the HepG2 cancer cell line.
No takes yet. Share an insight, caveat, or question.
Tupolova et al. (2023) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: